Dr. Meza is assistant professor in the Department of Epidemiology at the University of Michigan. He received his BSc in applied mathematics from the Instituto Tecnologico Autonomo de Mexico (ITAM), and his PhD in applied mathematics from the University of Washington. After receiving his PhD, Dr. Meza completed a two-year postdoctoral fellowship at the Fred Hutchinson Cancer Research Center - and a three-year fellowship at the University of British Columbia Centre for Disease Control.
Dr. Meza's research interests lie at the interface of epidemiology, biostatistics and biomathematics. In particular, he is interested in cancer risk assessment and the analysis of cancer epidemiology data using mechanistic models of carcinogenesis. He is also interested in the mathematical modeling of infectious disease dynamics and its applications in public health policy design. Dr. Meza is an active member of the Cancer Intervention and Surveillance Modeling Network (CISNET) lung and esophagus groups, and a core member of the Cancer Prevention and Control Program at the University of Michigan Comprehensive Cancer Center (UMCCC).
Currently, Dr. Meza is developing models to evaluate the impact of screening strategies on lung, colon and esophagus cancer risk. Additional projects include the development of methodologies to investigate the effects of infectious disease dynamics on the risk of cancers with infectious disease etiology, and the analysis of the long-term impact of in-utero and childhood conditions and exposures on adult mortality and cancer risk
1. Lau YK, Caverly TJ, Cao P, Cherng ST, West M, Gaber C, Arenberg D, Meza R. Evaluation of a personalized, web-based decision aid for lung cancer screening, American Journal of Preventive Medicine, in press
2. Levy DT, Meza R, Zhang Y, Holford TR. The Role of Tobacco Control Policies in Reducing U.S. Gauging the Effect of US Tobacco Control Policies from 1965-2014 Using SimSmoke American Journal of Preventive Medicine, in press
3. Meza R & Chang JT. Increasing thyroid cancer incidence in the United States: temporal trend analysis, age-period-cohort and multistage modeling, BMC Public Health,15:789, 2015
4. Brouwer AF, Meza R, Eisenberg MC. Transmission Heterogeneity and Autoinoculation in a Multisite Infection Model of HPV, Mathematical Biosciences, in press
5. Fleischer NL, Thrasher JF, Reynales-Shigematsu LM, Cummings KM, Meza R, Yang Z, Levy DT. Mexico SimSmoke: How Changes in Tobacco Control Policies Would Impact Smoking Prevalence and Smoking Attributable Deaths in Mexico. Global Public Health, in press
6. Meza R, Meernik C, Jeon J, Cote ML. Lung cancer incidence trends by gender, race and histology in the US, 1973-2010. PLos One, 10(3):e0121323, 2015
7. de Koning H, Meza R, Plevritis S, ten Haaf K, et al. Benefits and harms of CT lung cancer screening strategies. A comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 160(5), 311-320, 2014
8. Hazelton WD, Curtius K, Inadomi JM, Vaughan TL, Meza R, Rubenstein JH, Hur C, Luebeck E. The role of gastroesophageal reflux and other factors during progression to esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev., 24(7):1012-23, 2015
9. Jeon J, Meza R, Hazelton WD, Renehan A, Luebeck EG. Incremental benefits of screening colonoscopy over sigmoidoscopy in average risk population: A mathematical modeling study. Cancer Causes and Control, 26(6):859-70, 2015
10. Holford TR, Meza R, Warner KE, Meernik C*, Jeon J, Levy DT. Tobacco Control and the Reduction in Smoking-related Premature Deaths in the United States, 1964-2012. JAMA 311(2), 164-171, 2014